41 filings
Page 2 of 3
8-K
9mg fw06zv
7 Aug 19
Constellation Pharmaceuticals Announces Second-Quarter andSix-Month 2019 Financial Results
4:11pm
8-K
f2xuagc xmgxsjzzuv2
19 Jun 19
Entry into a Material Definitive Agreement
4:12pm
8-K
8ex4a x8j7r
10 Jun 19
Submission of Matters to a Vote of Security Holders
4:35pm
8-K
f2g3n
16 May 19
Constellation Pharmaceuticals Provides Interim Update of Data forCPI-0610 in ASCO and EHA Abstracts
9:01am
8-K
y4ozzp hk6
15 May 19
2019 ASCO Annual Meeting
5:01pm
8-K
r4lbfo7jbb3495dm8b6
8 May 19
Constellation Pharmaceuticals Announces First-Quarter 2019 Financial Results
4:21pm
8-K
ihirqb6
1 Apr 19
Constellation Pharmaceuticals Presents Results from Phase 1b Portion of ProSTAR Clinical Trial ofCPI-1205 at AACR Meeting
1:00pm
8-K
ym05uga8k t43vcq8
21 Mar 19
Entry into a Material Definitive Agreement
6:40am
8-K
df6p ekfqm7a8
14 Mar 19
Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2018 Financial Results
5:30pm
8-K/A
04s o5v0or780ep
13 Mar 19
Departure of Directors or Certain Officers
4:18pm
8-K
43k vm6k8itk0ym45d
20 Feb 19
Announces Appointment to Board of
7:12am
8-K
96rjqu1k9a5qdaek
7 Jan 19
Regulation FD Disclosure
6:39am
8-K
10iodt8647t0p
3 Jan 19
Regulation FD Disclosure
7:10am
8-K/A
i86i1dyb
17 Dec 18
Departure of Directors or Certain Officers
4:45pm
8-K
18kljx9yep4w
10 Dec 18
Regulation FD Disclosure
4:52pm
8-K
uqut8
9 Nov 18
Constellation Pharmaceuticals Announces Third-Quarter and Nine-Month 2018 Financial Results
12:00am
8-K
b94bs6i kerok1g5n
1 Nov 18
Constellation Pharmaceuticals Receives FDA Fast Track Designation forCPI-0610 in Treatment of Myelofibrosis
7:12am
8-K
nle222in sab0mptkpp
11 Oct 18
Constellation Pharmaceuticals Enhances and Expands Phase 2 MANIFEST Study ofCPI-0610 in Myelofibrosis
12:00am
8-K
17e926zhrnj1pjkogk
4 Sep 18
Constellation Pharmaceuticals Announces Appointments to Board of Directors
12:00am
8-K
3aks6ivnym0mc7za3 sm
14 Aug 18
Constellation Pharmaceuticals Announces Second-Quarter andSix-Month 2018 Financial Results
4:29pm